- Home
- TXG vs ADAMZ Comparison
TXG vs ADAMZ Comparison
Compare TXG & ADAMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXG
- ADAMZ
- Stock Information
- Founded
- TXG 2012
- ADAMZ N/A
- Country
- TXG United States
- ADAMZ United States
- Employees
- TXG N/A
- ADAMZ N/A
- Industry
- TXG Biotechnology: Laboratory Analytical Instruments
- ADAMZ Real Estate Investment Trusts
- Sector
- TXG Industrials
- ADAMZ Real Estate
- Exchange
- TXG Nasdaq
- ADAMZ Nasdaq
- Market Cap
- TXG 1.6B
- ADAMZ 1.6B
- IPO Year
- TXG 2019
- ADAMZ N/A
- Fundamental
- Price
- TXG $11.76
- ADAMZ $19.85
- Analyst Decision
- TXG Buy
- ADAMZ
- Analyst Count
- TXG 12
- ADAMZ 0
- Target Price
- TXG $13.54
- ADAMZ N/A
- AVG Volume (30 Days)
- TXG 2.7M
- ADAMZ N/A
- Earning Date
- TXG 10-28-2025
- ADAMZ N/A
- Dividend Yield
- TXG N/A
- ADAMZ N/A
- EPS Growth
- TXG N/A
- ADAMZ N/A
- EPS
- TXG N/A
- ADAMZ N/A
- Revenue
- TXG $644,466,000.00
- ADAMZ N/A
- Revenue This Year
- TXG $2.15
- ADAMZ N/A
- Revenue Next Year
- TXG N/A
- ADAMZ N/A
- P/E Ratio
- TXG N/A
- ADAMZ N/A
- Revenue Growth
- TXG 2.02
- ADAMZ N/A
- 52 Week Low
- TXG $6.78
- ADAMZ N/A
- 52 Week High
- TXG $20.92
- ADAMZ N/A
- Technical
- Relative Strength Index (RSI)
- TXG 41.80
- ADAMZ N/A
- Support Level
- TXG $11.22
- ADAMZ N/A
- Resistance Level
- TXG $13.22
- ADAMZ N/A
- Average True Range (ATR)
- TXG 0.57
- ADAMZ 0.00
- MACD
- TXG 0.00
- ADAMZ 0.00
- Stochastic Oscillator
- TXG 27.18
- ADAMZ 0.00
About TXG 10x Genomics Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).